CODX Insider Trading

Insider Ownership Percentage: 6.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Co-Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at Co-Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$4k-$2k$0$2k$4kTotal Insider BuyingTotal Insider Selling

Co-Diagnostics Share Price & Price History

Current Price: $0.80
Price Change: Price Increase of +0.0196 (2.53%)
As of 01/17/2025 05:00 PM ET

This chart shows the closing price history over time for CODX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
FebMarAprMayJunJulAugSepOctNovDecJan$0.80Closing price on 01/20/25:

Co-Diagnostics Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Co-Diagnostics (NASDAQ:CODX)

14.99% of Co-Diagnostics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CODX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
202220232024$35kbought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4-$100k$0$100kTotal InflowsTotal Outflows
Co-Diagnostics logo
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Read More on Co-Diagnostics

Today's Range

Now: $0.80
Low: $0.76
High: $0.80

50 Day Range

MA: $0.86
Low: $0.70
High: $1.17

52 Week Range

Now: $0.80
Low: $0.67
High: $2.23

Volume

74,478 shs

Average Volume

310,081 shs

Market Capitalization

$25.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Co-Diagnostics?

Co-Diagnostics' top insider investors include:
  1. Brian Lee Brown (CFO)
Learn More about top insider investors at Co-Diagnostics.